As of March 23, 2026, Context Therapeutics's top three insider holders are Martin A. Lehr (Chief Executive Officer, 920.19K shares), Martin A. Lehr (Chief Executive Officer, 159.70K shares), Evan G. Dick (Svp Of Rd, 82.96K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Martin A. Lehr | Chief Executive Officer | 0 | 920,190 | 10 Jun, 2025 |
| Martin A. Lehr | Chief Executive Officer | 159,701 | 0 | 21 Feb, 2023 |
| Evan G. Dick | Svp Of Rd | 82,960 | 0 | 17 Dec, 2021 |
| Jennifer Lynn Minai-Azary | Chief Financial Officer | 80,010 | 0 | 10 Jun, 2025 |
| Alex C. Levit | Chief Legal Officer, Corp. Sec | 29,000 | 0 | 10 Jun, 2025 |
| Tarek Sahmoud | Chief Medical Officer | 10,000 | 0 | 17 Aug, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 19 Feb, 2026 | Karen Deborah Chagin | Stock Option (right to buy) | A | 290,000 | $0.00 | 290,000 | D | A |
| 19 Feb, 2026 | Jennifer Lynn Minai-Azary | Stock Option (right to buy) | A | 275,000 | $0.00 | 275,000 | D | A |
| 19 Feb, 2026 | Martin A. Lehr | Stock Option (right to buy) | A | 815,000 | $0.00 | 815,000 | D | A |
| 19 Feb, 2026 | Alex C. Levit | Stock Option (right to buy) | A | 270,000 | $0.00 | 270,000 | D | A |
| 12 Jun, 2025 | Karen L. Smith | Stock Option (right to buy) | A | 123,500 | $0.00 | 123,500 | D | A |
| 12 Jun, 2025 | Luke Nathaniel Walker | Stock Option (right to buy) | A | 123,500 | $0.00 | 123,500 | D | A |
| 12 Jun, 2025 | Andy Pasternak | Stock Option (right to buy) | A | 138,900 | $0.00 | 138,900 | D | A |
| 12 Jun, 2025 | Jennifer Evans Stacey | Stock Option (right to buy) | A | 123,500 | $0.00 | 123,500 | D | A |
| 12 Jun, 2025 | Philip W. Kantoff | Stock Option (right to buy) | A | 123,500 | $0.00 | 123,500 | D | A |
| 12 Jun, 2025 | Linda West | Stock Option (right to buy) | A | 123,500 | $0.00 | 123,500 | D | A |
| 06 Jun, 2025 | Jennifer Lynn Minai-Azary | Common Stock | A | 40,010 | $0.64 | 80,010 | D | P |
| 09 Jun, 2025 | Martin A. Lehr | Common Stock | A | 100,000 | $0.70 | 920,190 | I | P |
| 06 Jun, 2025 | Alex C. Levit | Common Stock | A | 20,000 | $0.58 | 29,000 | D | P |
| 09 Jun, 2025 | Karen Deborah Chagin | Stock Option (right to buy) | A | 153,000 | $0.00 | 153,000 | D | A |
| 13 Feb, 2025 | Martin A. Lehr | Stock Option (right to buy) | A | 802,700 | $0.00 | 802,700 | D | A |
| 13 Feb, 2025 | Alex C. Levit | Stock Option (right to buy) | A | 349,900 | $0.00 | 349,900 | D | A |
| 13 Feb, 2025 | Jennifer Lynn Minai-Azary | Stock Option (right to buy) | A | 371,800 | $0.00 | 371,800 | D | A |
| 13 Feb, 2025 | Ullmann Claudio Dansky | Stock Option (right to buy) | A | 174,960 | $0.00 | 174,960 | D | A |
| 13 Jan, 2025 | Andy Pasternak | Stock Option (right to buy) | A | 20,685 | $0.00 | 20,685 | D | A |
| 04 Sep, 2024 | Karen L. Smith | Stock Option (right to buy) | A | 19,315 | $0.00 | 19,315 | D | A |